CLIA Inspection Checklist: Key Requirements Every Lab Must Meet

A CLIA inspection can arrive with little warning. Whether you’re preparing for a scheduled biennial survey or a CMS validation inspection, the documentation your inspector wants to see is either organized and ready, or it isn’t.

This CLIA inspection checklist covers all 10 requirement categories under 42 CFR Part 493, with a little over 50 specific checkpoints your lab should be able to verify before any inspector walks through the door. It’s designed to function as a practical CLIA audit checklist: scan it, check off what you have, and identify the gaps that need immediate attention.

You can use it as a CLIA survey checklist in the months leading up to your next cycle, as a CLIA compliance checklist for internal QA reviews, or as a baseline CLIA competency assessment template for staff evaluation programs. 

Whatever your certificate type (compliance, accreditation, or PPM), most of these requirements apply.

The CLIA Inspection Checklist: All 10 Requirement Categories 

The categories below map to the core subparts of 42 CFR Part 493. Each item represents a documentation requirement, operational standard, or testable process your inspector may review. 

Use this as your master laboratory audit checklist ahead of any CLIA survey.

1. Certificate & Facility Requirements

• 1.1 Current CLIA certificate is posted or immediately accessible at the testing site.
• 1.2 Certificate type matches the complexity level of tests actually being performed.
• 1.3 Lab’s name, address, and director information on the certificate are current and accurate.
• 1.4 Any changes to ownership, directorship, or testing location have been reported to CMS within the required timeframe.
• 1.5 Lab has an active and verifiable CLIA identification number on all required forms and correspondence.

2. Personnel Qualifications

• 2.1 Laboratory Director meets the qualification requirements for the certificate type and test complexity level performed (moderate or high complexity).
• 2.2 Technical Supervisor (high complexity labs) holds the required degree, training, and experience as specified under 42 CFR 493.1449.
• 2.3 Clinical Consultant credentials are documented and on file.
• 2.4 General Supervisor (moderate complexity) meets applicable educational and experience requirements.
• 2.5 Testing personnel credentials, including degrees, training records, and applicable licenses, are on file for every individual performing patient testing.
• 2.6 Any delegation of supervisory or assessment duties is documented in writing and reflects the December 2024 Final Rule updates harmonizing moderate and high complexity delegation requirements.

3. Competency Assessment

CLIA requires competency assessment at least semi-annually during the first year an individual tests patient specimens, and annually thereafter for all six required elements.

• 3.1 All testing personnel have documented competency assessments covering all six required elements: direct observation, monitoring and reporting of results, review of QC records, proficiency testing performance, review of test results for accuracy, and problem-solving.
• 3.2 Assessments were completed semi-annually during the employee’s first year of testing.
• 3.3 Annual competency assessments are current for all staff performing patient testing.
• 3.4 Competency records are organized by individual, test system, and date and not consolidated into a single blanket form.
• 3.5 Any assessor performing competency evaluations meets the qualification requirements under 42 CFR 493.1451, and delegation is documented in writing where applicable.

4. Procedure Manual (Standard Operating Procedures)

In 2023, CAP cited procedure manual deficiencies as the single most common finding across accredited labs; 741 citations in one reporting cycle. An outdated or incomplete SOP is an easy-to-find, hard-to-explain gap. 

• 4.1 A written procedure manual exists and is accessible at the workbench for all tests performed.
• 4.2 Each procedure includes: test principle, specimen type and collection, reagents, equipment, calibration, QC requirements, step-by-step instructions, results reporting, and reference intervals.
• 4.3 Procedures are reviewed, approved, and signed by the current laboratory director (not a predecessor).
• 4.4 All procedures reflect current practice. Any test that has been added, modified, or discontinued is updated in the manual and dated accordingly.
• 4.5 Discontinued procedures are retained for at least two years from the date of discontinuation.

5. Quality Control (QC)

Quality control is one of the broadest inspection categories and covers both the mechanics of running controls and the documentation that proves they were run correctly.

• 5.1 QC is performed at the frequency specified by the manufacturer or, where manufacturer instructions are absent, per lab policy — at minimum each day of patient testing.
• 5.2 Two levels of controls (normal and abnormal) are run for each quantitative test system.
• 5.3 QC results are reviewed by a qualified supervisor before patient results are reported.
• 5.4 Out-of-control events are documented with the corrective action taken and outcome.
• 5.5 QC records, including lot numbers, expiration dates, results, and reviewer signatures, are retained for a minimum of two years.
• 5.6 QC procedures are appropriate to the test system and follow manufacturer recommendations; any deviation from manufacturer instructions is documented with justification.

6. Proficiency Testing (PT)

Proficiency testing enrollment and performance documentation is a mandatory, testable requirement, and a commonly missed one.

• 6.1 Lab is enrolled in a CMS-approved proficiency testing program for all regulated analytes it performs.
• 6.2 PT specimens are tested by the same personnel, using the same methods, and under the same conditions as patient specimens — no special handling.
• 6.3 PT is performed at least twice per year (biannually) for all applicable nonwaived tests under 42 CFR 493.1236(c)(1).
• 6.4 PT results are submitted to the approved program within the required timeframe.
• 6.5 PT performance records (scores, unsatisfactory events, and any corrective actions) are retained for at least two years.
• 6.6 Lab director has reviewed and signed PT result documentation for each testing event.

7. Test System Performance & Method Validation

Before any test system is used for patient testing, its performance specifications must be verified, and that verification must be documented.

• 7.1 Performance specifications (accuracy, precision, reportable range, reference intervals) have been verified or established for each test system prior to patient use.
• 7.2 High complexity tests that are laboratory-developed or substantially modified have full validation documentation on file.
• 7.3 Reference intervals are documented and appropriate for the patient population served.
• 7.4 Reportable range verification is documented per manufacturer specifications.
• 7.5 Instrument comparability studies are documented for labs running the same test on multiple instruments or platforms, a growing deficiency category that ranked among the top findings in recent CAP data (694 citations in 2023).

8. Equipment Maintenance & Calibration

This is an often overlooked aspect of CLIA inspections but equipment and instrument maintenance is absolutely critical to inspection passes.

• 8.1 A maintenance schedule exists for each instrument, consistent with manufacturer instructions under 42 CFR Part 493 Subpart K.
• 8.2 Maintenance logs are current and include: task performed, date, and the name and credentials of the individual who performed it.
• 8.3 Corrective action is documented for any instrument found out of specification during a maintenance check.
• 8.4 Calibration is performed and documented at the frequency specified by the manufacturer.
• 8.5 Calibration verification (not the same as calibration) is performed at least every six months for quantitative tests, when reagent lots change, and after major maintenance events.

9. Preanalytic & Postanalytic Systems

Inspectors assess the full testing cycle so any gaps in laboratory accessioning and result documentation are increasingly scrutinized areas. 

• 9.1 Specimen collection and handling requirements (labeling, transport conditions, rejection criteria) are documented and communicated to all collection sites.
• 9.2 Criteria for specimen rejection are written, followed consistently, and documented when a specimen is rejected.
• 9.3 Patient reports include all required elements: patient name and ID, physician name, date of collection, date of report, test result, reference intervals, and lab name/address.
• 9.4 Critical values have a defined notification policy, and documentation of critical value communications is retained.
• 9.5 Amended reports clearly identify the change, the reason for the amendment, and the date of the amended report.

10. General Laboratory Systems & Safety

A more general category to keep in mind but still integral to your inspection success.

• 10.1 A Quality Assessment (QA) program exists and is documented, including a mechanism for identifying and correcting problems across the total testing process.
• 10.2 Patient test records are retained for at least two years (or longer if state law requires).
• 10.3 A written safety policy is in place, covering chemical, biological, and physical hazard protocols.
• 10.4 Safety data sheets (SDS) are accessible for all hazardous materials in use.
• 10.5 The lab has documented policies for handling and disposal of biohazardous waste, including chain-of-custody documentation where applicable.

How to Prepare Your Lab for a CLIA Inspection 

Here’s a practical timeline that works for lab directors and QA managers alike. 

90 Days Out

• Pull all personnel files and verify credentials, training, and annual competency assessments are current for every testing employee.
• Review your procedure manual against active test systems. Flag any procedure that hasn’t been reviewed by the current director in the past year.
• Confirm PT enrollment covers all regulated analytes. Check that your last two PT events are documented, scored, and signed.

30 Days Out

• Audit QC logs for the past six months. Look for out-of-control events that lack documented corrective action.
• Verify calibration and calibration verification records are complete and date-stamped correctly.
• Review equipment maintenance logs for any gaps in scheduled tasks.
• Confirm your CLIA certificate is current, posted, and reflects accurate directorship and location information.

Week Before

• Ensure testing personnel know they may be interviewed or observed during the inspection.
• Confirm all records are organized and accessible at the workbench, not locked in a director’s office.
• Brief staff on specimen rejection, critical value notification, and result reporting protocols.
• Run a walkthrough using this checklist as your final CLIA compliance checklist.

Keep Your Lab Inspection-Ready Year-Round with Onymos 

Inspection failures rarely come from a single missing document. Fragmented workflows are often the main culprit. Think: patient data entered manually, requisition forms processed inconsistently, and QC records stored in disconnected systems that nobody’s reconciled in six months. 

Onymos DocKnow helps diagnostic and clinical laboratories build the clean, connected data pipelines that make compliance documentation a byproduct of day-to-day operations, not a pre-inspection scramble. From laboratory accessioning through billing and reimbursement, the labs that stay inspection-ready are the ones where data flows accurately from the first touchpoint.

Want to see where documentation gaps are costing your lab? Talk to the Onymos team or explore the best intelligent document processing solutions to upscale your documentation workflows today.

FAQs 

What Is a CLIA Inspection and Who Does It Apply To?

Under 42 CFR Part 493, any laboratory that tests human specimens for health assessment or disease diagnosis must hold a CLIA certificate and permit CMS, or a CMS-approved agent, to conduct compliance inspections. This applies to clinical and diagnostic laboratories of all sizes, from high-volume reference labs to hospital-based testing facilities.

There are four certificate types to be aware of:

• Certificate of Waiver
• Certificate for Provider-Performed Microscopy (PPM)
• Certificate of Compliance
• Certificate of Accreditation 

Labs holding a Certificate of Compliance are subject to routine on-site surveys subject to validation and complaint inspections, and survey timing depends on certificate type and accrediting-body cycle. Accredited labs face validation and complaint inspections in addition to their accrediting body’s own review cycle. 

Inspectors evaluate the full scope of your laboratory operations and failure to permit an inspection can result in suspension or revocation of your CLIA certificate and loss of Medicare and Medicaid reimbursement eligibility. 

What is a CLA laboratory?

A CLIA laboratory is any facility that tests human specimens for health assessment, disease diagnosis, prevention, or treatment, and is certified under the Clinical Laboratory Improvement Amendments of 1988 (42 CFR Part 493).

What happens if a lab fails a CLIA inspection?

Failing a CLIA inspection can result in civil monetary penalties, suspension or limitation of the lab’s CLIA certificate, and loss of eligibility for Medicare and Medicaid reimbursement. The severity of sanctions depends on the type and scope of deficiencies cited. Labs have the right to appeal, and some sanctions are held pending that process. 

Is a CLIA inspection the same as a CAP inspection?

No, though they cover much of the same ground. A CAP (College of American Pathologists) inspection is conducted by a CMS-approved accrediting organization as an alternative to a direct CMS compliance survey. Labs with a Certificate of Accreditation still have their CAP inspections validated by CMS and can be subject to unannounced CMS validation inspections at any time.